Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Transplant Proc ; 49(1): 73-77, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28104163

RESUMO

BACKGROUND: Hyperuricemia is a common adverse event frequently found in renal transplant recipients with mizoribine (MZ). Hyperuricemia itself will be a cause of renal dysfunction, and renal dysfunction also will be a cause of hyperuricemia simultaneously. This study investigates frequency of hyperuricemia and renal failure in renal transplant recipients treated with high-dose MZ. PATIENTS AND METHODS: From December 2007 to October 2015, there was a total of 32 living related renal transplant recipients treated with high-dose MZ. Of the 32 patients, 28 were treated with urate-lowering medications. RESULTS: One patient received allopurinol (AP) and 13 patients received benzbromarone (BB). For 6 of them, their urate-lowering medications were converted to febuxostat (FX) form AP or BB. In the remaining 14 patients, FX was administered from the beginning. In 2 cases of ABO-incompatible living related renal transplant recipients who were maintained with high-dose MZ and BB, severe hyperuricemia and acute renal failure occurred. One patient was a 48-year-old man, and his creatinine (Cr) level increased to 8.14 mg/dL and his serum uric acid (UA) was 24.6 mg/dL. Another patient was a 57-year-old man, and his Cr level increased to 3.59 mg/dL and his UA was 13.2 mg/dL. In both cases Cr and UA were improved, and no finding of acute rejection and drug toxicity was observed in graft biopsy specimens. BB was switched to FX and discontinuance or reduction of MZ was done. CONCLUSION: Combination of MZ and BB has the risk of acute renal dysfunction after renal transplantation. Latent renal dysfunction should be watched for in renal transplant recipients receiving high-dose MZ.


Assuntos
Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/etiologia , Hiperuricemia/epidemiologia , Hiperuricemia/etiologia , Transplante de Rim/efeitos adversos , Adulto , Alopurinol/uso terapêutico , Benzobromarona/efeitos adversos , Febuxostat/uso terapêutico , Humanos , Imunossupressores/efeitos adversos , Masculino , Pessoa de Meia-Idade , Ribonucleosídeos/efeitos adversos , Ribonucleosídeos/uso terapêutico , Transplantados , Ácido Úrico/sangue , Uricosúricos/efeitos adversos
2.
Arch Oral Biol ; 45(8): 639-45, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10869475

RESUMO

Cacao bean husk extract (CBH) was examined for inhibitory effects on the caries-inducing properties of mutans streptococci in vitro and on caries development in specific pathogen-free Sprague-Dawley rats infected with mutans streptococci. CBH reduced the growth rate of almost all oral streptococci examined, which resulted in the reduction of acid production. Furthermore, insoluble glucan synthesis by the glucosyltransferases from Streptococcus mutans MT8148R and Streptococcus sobrinus 6715 was significantly inhibited by CBH. Hence, the sucrose-dependent cell adherence of mutans streptococci was also depressed by CBH. The administration of CBH in drinking water resulted in significant reductions of caries development and dental plaque accumulation in rats infected with either Strep. sobrinus 6715 or Strep. mutans MT8148R, and the minimum cariostatic concentration was 1.0 mg/ml. These results indicate that CBH possesses powerful anticariogenic potential.


Assuntos
Cacau/uso terapêutico , Cariostáticos/uso terapêutico , Cárie Dentária/prevenção & controle , Fitoterapia , Estruturas Vegetais/uso terapêutico , Análise de Variância , Animais , Aderência Bacteriana/efeitos dos fármacos , Cárie Dentária/microbiologia , Placa Dentária/prevenção & controle , Análise Fatorial , Glucanos/metabolismo , Glucosiltransferases/antagonistas & inibidores , Masculino , Extratos Vegetais/uso terapêutico , Polissacarídeos Bacterianos/metabolismo , Ratos , Ratos Sprague-Dawley , Solubilidade , Organismos Livres de Patógenos Específicos , Streptococcus mutans/efeitos dos fármacos , Streptococcus mutans/enzimologia , Streptococcus mutans/crescimento & desenvolvimento , Streptococcus sobrinus/efeitos dos fármacos , Streptococcus sobrinus/enzimologia , Streptococcus sobrinus/crescimento & desenvolvimento , Sacarose/metabolismo , Abastecimento de Água
3.
Arch Oral Biol ; 45(9): 805-8, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10869494

RESUMO

Chocolate is suspected to contain some caries-inhibitory substances. The cariostatic activity of cacao mass extract (CM), the main component of chocolate, was examined in vitro and in experimental animals. CM showed no detectable effects on the cellular growth and acid production of mutans streptococci. On the other hand, the cell-surface hydrophobicity of mutans streptococci was significantly reduced by the presence of CM. Furthermore, insoluble glucan synthesis by the glucosyltransferases from either Streptococcus mutans MT8148R or Strep. sobrinus 6715 was inhibited by CM, but not significantly. Hence, the sucrose-dependent cell adherence of mutans streptococci was also depressed by CM. Finally, CM in both a 40% sucrose diet and drinking water resulted in reductions of caries development and plaque accumulation in rats infected with Strep. sobrinus 6715, but not significantly. These results indicate that cacao mass extract possesses some anticariogenic potential, but its anticaries activity is not strong enough to suppress significantly the cariogenic activity of sucrose.


Assuntos
Cacau , Cariostáticos/farmacologia , Extratos Vegetais/farmacologia , Animais , Aderência Bacteriana/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Glicosiltransferases/antagonistas & inibidores , Masculino , Ratos , Ratos Sprague-Dawley , Streptococcus mutans/efeitos dos fármacos , Streptococcus mutans/enzimologia , Streptococcus sobrinus/efeitos dos fármacos , Streptococcus sobrinus/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA